Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
144.77
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Johnson & Johnson
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Is Amazon a Blue Chip Stock?
February 28, 2023
Is Amazon a blue chip stock or does it fit into a different category? Learn more about Amazon.com Inc. and how to categorize it with MarketBeat.
Via
MarketBeat
What Are Dividend Payment Dates?
February 21, 2023
What are dividend payment dates? The payment date is the day a company pays its eligible shareholders dividends. Learn more.
Via
MarketBeat
Johnson & Johnson: Taking The Bull By The Horns?
February 21, 2023
Johnson & Johnson is rushing toward a patent cliff but a new shelf offering registration suggests itis gearing up for acquisitions.
Via
MarketBeat
Topics
Intellectual Property
Regulatory Compliance
Exposures
Intellectual Property
Legal
Regulatory
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors
February 14, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the Barclays Global HealthCare Conference
February 14, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
February 13, 2023
From
Johnson & Johnson
Via
Business Wire
Pain Relief Medication Market to Witness Huge Growth by Key Players: Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline Plc.
February 08, 2023
Global Pain Relief Medication Market By Material (Acute, Chronic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
Via
SBWire
MarketBeat Week in Review – 1/30 - 2/3
February 04, 2023
The markets are trending lower to end the week. It’s hard to figure out the markets after the blockbuster job report, but the MarketBeat team gave it a shot
Via
MarketBeat
Topics
Artificial Intelligence
Earnings
Economy
Exposures
Artificial Intelligence
Financial
Interest Rates
Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference
February 02, 2023
From
Johnson & Johnson
Via
Business Wire
Liposome Drug Delivery Market 2023 in-Depth Analysis, Growth, Size, Future Prospect, Regional Development and Global Outlook 2029
February 02, 2023
Liposome Drug Delivery Market Size, Share and Forecast 2023-2029 Key Players are – Ipsen Pharma, Celsion Corp, Gilead Sciences, Astellas Pharma, Johnson & Johnson, Luye Pharma Group, Novartis AG
Via
SBWire
Exposures
COVID-19
Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium
February 01, 2023
SAN DIEGO, February 1, 2023 (Newswire.com) - On Feb. 26, 2022, Rancho Biosciences, a leading data sciences services company, launched its Single Cell Data Science (SCDS) pre-competitive consortium,...
Via
Newswire.com
How Do Lawsuits Affect Johnson & Johnson's Stock Price?
February 01, 2023
JNJ's stock price was hit hard on Monday following the court's ruling for billions of dollars worth of lawsuits - what does this mean for investors?
Via
MarketBeat
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Legal
Osteotomy Plates Market Share with Top Countries Data, Size, Global Industry Challenges, Business Overview and Forecast Research Study 2028
January 30, 2023
Osteotomy Plates SWOT Analysis Including Key Players - Arthrex, Acumed, Medartis, Johnson & Johnson, Group Fh Ortho, B. Braun Melsungen, Zimmer Biomet, Stryker Corporation, aap Implantate, Wright...
Via
SBWire
Topics
Supply Chain
Exposures
Supply Chain
Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
January 26, 2023
Johnson & Johnson and Abbott Laboratories are 2 dividend kings guiding for growth in 2023 and are on track to increase their yield yet again.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
January 25, 2023
Five biotechs have already issued layoffs in 2023. Many seem to have good potential, but time will tell if the shifts create the value analysts anticipate.
Via
MarketBeat
Topics
Workforce
Exposures
Layoff
Product Safety
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
January 24, 2023
From
Johnson & Johnson
Via
Business Wire
MarketBeat Week in Review – 1/16 - 1/20
January 21, 2023
The shortened trading week looks to be ending on a sour note over growing recession fears. Here are some of the top stories from our MarketBeat contributors
Via
MarketBeat
Topics
Economy
Workforce
Exposures
Economy
Layoff
AbbVie Stock: Dividend King ABBV Overview
January 19, 2023
Via
MarketBeat
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
January 18, 2023
From
Johnson & Johnson
Via
Business Wire
Drug Delivery Market – Major Technology Giants in Buzz Again : Johnson & Johnson, Sanofi, Pfizer
January 18, 2023
How to reach that market place and its associated audience with current marketing efforts? Benchmark now the competitive efforts with high growth emerging players and leaders of Drug Delivery Market.
Via
SBWire
Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
January 18, 2023
Johnson & Johnson stock has been struggling to break out of a correction. It formed a cup-shaped pattern that appeared to add a handle but broke down last week.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
3 Dividend Stocks For Passive Income
January 17, 2023
I'm aiming to grow my passive income this year through adding these safe value stocks to my portfolio that have strong dividend yields.
Via
MarketBeat
Topics
Economy
Exposures
Economy
These Steelmakers Deserve A Place On Your 2023 Watch List
December 23, 2022
Steel stocks including Nucor and Steel Dynamics are bringing holiday cheer to investors as they have potential to benefit from infrastructure spending in 2023.
Via
MarketBeat
Johnson & Johnson Completes Acquisition of Abiomed
December 22, 2022
From
Johnson & Johnson
Via
Business Wire
Financial Resources Federal Credit Union Taps Scienaptic's Platform to Power its Credit Decisions With AI
January 11, 2023
NEW YORK - Jan. 11, 2023 - PRLog -- Leading global AI-powered credit decision platform provider, Scienaptic AI, announced today that Financial Resources Federal Credit Union has chosen to implement its...
Via
PRLog
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022
December 14, 2022
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
December 13, 2022
From
Johnson & Johnson
Via
Business Wire
Two Blue Chip Health Companies The Institutions Are Buying
December 12, 2022
Johnson & Johnson and Abbott Laboratories are two Dividend Kings the analysts are buying, one stock is ready to rebound and the other to lead the market.
Via
MarketBeat
MarketBeat: Week in Review 12/05 – 12/09
December 10, 2022
The markets continue to have a lot to digest before there can be a Santa Claus raly. Here are some of the top stories our analysts were covering this week.
Via
MarketBeat
Topics
Economy
Electric Vehicles
Supply Chain
Exposures
Electric Vehicles
Interest Rates
Supply Chain
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
December 09, 2022
Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months.
Via
MarketBeat
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.